title: The challenge of acute rejection in intestinal transplantation.
abstract: Early diagnosis and treatment of acute cellular rejection (ACR) after intestinal transplantation (ITx) is challenging. We report the outcome of three patients: two presented mild ACR improved with steroids. One presented steroid-resistant severe rejection, improved after rabbit anti-thymocyte globulin (r-ATG), but unfortunately died for encephalitis caused by opportunistic infections.
authors: Department of Hepatobiliary, Pancreas, Transplantation and Pediatric Surgery, Kyoto University Hospital, Graduate School of Medicine, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto city, 606-8507, Japan. elenayy@yahoo.com
authors: E Y
authors: EY
authors: Yoshitoshi
authors: A
authors: A
authors: Yoshizawa
authors: E
authors: E
authors: Ogawa
authors: M
authors: M
authors: Kaneshiro
authors: N
authors: N
authors: Takada
authors: S
authors: S
authors: Okamoto
authors: Y
authors: Y
authors: Fujimoto
authors: S
authors: S
authors: Sakamoto
authors: S
authors: S
authors: Masuda
authors: M
authors: M
authors: Matsuura
authors: H
authors: H
authors: Nakase
authors: Y
authors: Y
authors: Nakase
authors: T
authors: T
authors: Chiba
authors: T
authors: T
authors: Tsuruyama
authors: H
authors: H
authors: Haga
authors: S
authors: S
authors: Uemoto
mesh_terms: D000293:Adolescent; D000714:Anastomosis, Surgical; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D000077552:Basiliximab; D002648:Child; D000077561:Daclizumab; D004660:Encephalitis / Q000209:etiology; D017809:Fatal Outcome; D005260:Female; D006084:Graft Rejection / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007410:Intestinal Diseases / Q000601:surgery; D045822:Intestinal Volvulus / Q000601:surgery; D007422:Intestines / Q000637:transplantation*; D008297:Male; D009422:Nervous System Diseases / Q000601:surgery; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D012778:Short Bowel Syndrome / Q000601:surgery; D016559:Tacrolimus / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000961:Antilymphocyte Serum; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab; D000077561:Daclizumab; D016559:Tacrolimus